Comparative bioavailability trials are crucial for assessing drug bioequivalence. Current statistical analysis methods are often irrelevant, suggesting a shift towards estimation procedures for therapeutic equivalence.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: